US directs $1 billion to H1N1 vaccine development
This article was originally published in Scrip
Executive Summary
The US health and human services department (HHS) will spend about $1 billion in existing funds for the commercial scale production and clinical trial development of a novel influenza A/H1N1 vaccine.